Sexual function of in diabetic patients. Sexual dysfunction not due to a substance or known physiological condition
Conditions
Interventions
Intervention 1: Intervention group: recipient of ginseng capsules, containing 100 mg of ginseng, prepared by Dana company, two capsules per day, for 8 weeks. Intervention 2: Control group: Placebo cap
Sponsors
Yasouj University of Medical Sciences
Eligibility
Sex/Gender
All
Age
35 Years to 55 Years
Inclusion criteria
Inclusion criteria: Heterosexual men and women aged 35 to 55 Who have been sexually active for at least 6 months Who will be sexually active in the next 8 weeks Who will obtain approval score score on the relevant sexual dysfunction questionnaire
Exclusion criteria
Exclusion criteria: Any physical disability that can limit sexual function Receiving any treatment for any sexual disorder in the past 6 months Prescribing Coumadin, warfarin, heparin, dalteparin, enoxaparin, or any other anticoagulant therapy Prescribing levodopa for Parkinson's disease or calciputerin for psoriasis Diagnosing high blood pressure and prescribing antihypertensive drugs Severe renal or hepatic failure Anatomical anomalies of the reproductive system Uncontrolled diabetes mellitus History of spinal cord injury Uncontrolled sexual secondary mental disorders Diagnosed prostate cancer or benign hypertrophy History of genital surgery History of chronic alcohol or drug abuse Suspected or diagnosed allergy to ginseng Participation in any other clinical trial in the past 30 days
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Women's orgasmic performance scores. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Female Sexual Function Index (FSFI).;Premature ejaculation performance of patients. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: The international index of erectile function (IIEF).;Sexual desire/arousal. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: The international index of erectile function (IIEF) and Female Sexual Function Index (FSFI).;Erectile dysfunction scores of patients. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: The international index of erectile function (IIEF) and Female Sexual Function Index (FSFI).;Delayed ejaculation scores. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: The international index of erectile function (IIEF) and Female Sexual Function Index (FSFI).;Determination of LDL, HDL, testosterone, prolactin and HBA1C levels. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Calibrated laboratory instruments. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Rahami
Yasouj University of Medical Sciences
Outcome results
None listed